Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure
2009
Guidelines for the Prevention of Stroke in Women
2014
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
1999 Standout
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy
2002
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Entropy, entropy rate, and pattern classification as tools to typify complexity in short heart period variability series
2001
Survival in octogenarians receiving implantable defibrillators
2006
Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators<SUBTITLE>The OPTIC Study: A Randomized Trial</SUBTITLE>
2006
Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more
2006
RIM Proteins Tether Ca2+ Channels to Presynaptic Active Zones via a Direct PDZ-Domain Interaction
2011 StandoutNobel
Synchronization and rhythmic processes in physiology
2001 Nature
High Diagnostic Yield and Accuracy of History, Physical Examination, and ECG in Patients with Transient Loss of Consciousness in FAST: The Fainting Assessment Study
2007
Inappropriate ICD Discharges in Single‐Chamber Versus Dual‐Chamber Devices in the Pediatric and Young Adult Population
2008
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy
2004
Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America
2008
Quality of Life in Patients with Atrial Fibrillation: A Systematic Review
2006
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications
2015
Randomized Clinical Trials of Neurally Mediated Syncope
2003
The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Study protocol
2000
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
2004
Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT‐II Substudy
2007
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
2006
The Managed Ventricular Pacing™ Versus VVI 40 Pacing (MVP) Trial: Clinical Background, Rationale, Design, and Implementation
2006
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Transtelephonic Monitoring and Transmission of Stored Arrhythmia Detection and Therapy Data From an Implantable Cardioverter Defibrillator
1995
Noninvasive Risk Assessment Early After a Myocardial Infarction
2007
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Syncope in the Patient with Nonischemic Dilated Cardiomyopathy
2004
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Long-Term Follow-Up of Implantable Cardioverter-Defibrillator for Secondary Prevention in Chagas' Heart Disease
2012
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Molecular basis of ancestral vertebrate electroreception
2017 StandoutNatureNobel
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
2012
The effect of hypoxia in development
2007
Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial
2010
Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
2009
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
2002 Standout
An SCN9A channelopathy causes congenital inability to experience pain
2006 StandoutNature
Efficacy of Ibutilide for Termination of Atrial Fibrillation and Flutter
1996
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
2010
Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries
2002
Implantable Cardioverter Defibrillators in Patients with Valvular Cardiomyopathy
2012
Long-Term Outcomes of Out-of-Hospital Cardiac Arrest after Successful Early Defibrillation
2003
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
2008
Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists
2013
A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease
1993
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation
2007
Value of non-invasive and invasive studies in patients with bundle branch block, syncope and history of myocardial infarction
2001
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Sudden Cardiac Death: Exploring the Limits of Our Knowledge
2001
Scope and nature of sudden cardiac death before age 40 in Ontario: A report from the Cardiac Death Advisory Committee of the Office of the Chief Coroner
2012
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Multiscale Entropy Analysis of Complex Physiologic Time Series
2002 Standout
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
1997 StandoutNobel
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Inducción de arritmias ventriculares por estimulación antibradicardia apropiada en pacientes portadores de desfibrilador automático
2001
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance
2009
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Cigarette smoking and risk of atrial fibrillation: The Rotterdam Study
2008
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
2006
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention
2011
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
2000
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Cardiac Myxomas
1995 Standout
Hypertrophic Cardiomyopathy
2002 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT
2003
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator
2002
Percent right ventricular pacing predicts outcomes in the DAVID trial
2005
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
2005
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial
2010
Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy
2003
International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels
2005 Standout
Quality of life in the Canadian Implantable Defibrillator Study (CIDS)
2002
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
2005
Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”
2007
Clinical Subtypes of Lone Atrial Fibrillation
2005
Complications Associated With Implantable Cardioverter-Defibrillator Replacement in Response to Device Advisories
2006
Secondary Prevention of Sudden Death
2000
Atrial Fibrillation
2001
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Implantable Cardioverter-Defibrillators in patients with arrhythmogenic right ventricular Dysplasia/Cardiomyopathy
2004
Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients
2004
Defibrillation Thresholds and Perioperative Mortality Associated with Endocardial and Epicardial Defihrillation Lead Systems
1993
Risk stratification for sudden cardiac death: current status and challenges for the future
2014
Detection of Previously Undiagnosed Atrial Fibrillation in Patients With Stroke Risk Factors and Usefulness of Continuous Monitoring in Primary Stroke Prevention
2012
Evaluating and improving the cost-effectiveness of the implantable cardioverter—defibrillator
1995
Impact of Viability, Ischemia, Scar Tissue, and Revascularization on Outcome After Aborted Sudden Death
2003
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
2005 Standout
Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
1999
Blockade of cardiac sodium channels by lidocaine. Single-channel analysis.
1989
Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator
2004
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
Two Isoforms of the MouseEther-a-go-go–Related Gene Coassemble to Form Channels With Properties Similar to the Rapidly Activating Component of the Cardiac Delayed Rectifier K+Current
1997
Cyclic AMP-dependent regulation of the number of [3H]batrachotoxinin benzoate binding sites on rat cardiac myocytes
1991
HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte
1998 Standout
Implantable Cardioverter Defibrillator Therapy
2000
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator
2001
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Characterization of Different Subsets of Atrial Fibrillation in General Practice in France
1999
Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope
2001
Antiarrhythmics Versus Implantable Defibrillators (AVID)—Rationale, design, and methods
1995
Cost and outcome implications of the organisation of vascular services.
2000
Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator
1995
Complex networks: Structure and dynamics
2006 Standout
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Part 9: Post–Cardiac Arrest Care
2010 Standout
Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias
2013
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients
2005
Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone
2004
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Evolving Indications for Permanent Pacemakers
2001
Implantable Cardioverter Defibrillators in Primary and Secondary Prevention
2003
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias
2007
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias
2002
Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy
2013
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Contemporary Pacemaker and Defibrillator Device Therapy
2007
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
2009
Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists
1975 StandoutNobel
Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators
1998
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Neuronal Oscillations in Cortical Networks
2004 StandoutScience
Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance
2005
Fractal dynamics in physiology: Alterations with disease and aging
2002 Standout
Design and Results of the Antiarrhythmics vs Implantable Defibrillators (AVID) Registry
1999
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator
2002
Transthoracic Cardioversion of Atrial Fibrillation
2000
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Part III
1999
Dual-Chamber Pacing in the Treatment of Neurally Mediated Tilt-Positive Cardioinhibitory Syncope
2000
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Asymptomatic or “Silent” Atrial Fibrillation
2003
Identification of a specific radioligand for the cardiac rapidly activating delayed rectifier K+ channel.
1993
Catecholamine binding to the beta-adrenergic receptor.
1977 StandoutNobel
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotype
2011 StandoutNobel
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Robert S. Sheldon being referenced
The relationship between health-related quality of life and frequency of spells in patients with syncope
2000
Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators
2003
The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: Rationale and study design
2006
Statin use and recurrence of atrial fibrillation after successful cardioversion
2007
Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system
1993
Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy?
2001
Effect of Dual-Chamber Pacing With Automatic Rate-Drop Sensing on Recurrent Neurally Mediated Syncope
1998
Timing of First Recurrence of Syncope Predicts Syncopal Frequency After a Positive Tilt Table Test Result
1997
The implantable cardioverter-defibrillator
2001
Randomized Controlled Trial of Fixed Rate Versus Rate Responsive Pacing After Radiofrequency Atrioventricular Junction Ablation:
2003
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design
2008
Definition of Predicted Effective Antiarrhythmic Drug Therapy for Ventricular Tachyarrhythmias by the Electrophysiologic Study Approach: Randomized Comparison of Patient Response Criteria
1997
Historical criteria that distinguish syncope from seizures
2002
Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation
2008
Isoproterenol Tilt-Table Testing in Patients With Syncope and Structural Heart Disease * *This article was supported by grants from the Medical Research Council of Canada, Ottawa, Ontario, and the Calgary General Hospital Research and Development Committee, Calgary, Alberta, Canada.
1996
Panel consensus
1999
Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope
2003
Intraventricular Masses Detected by Radionuclide Angiocardiography
1987
Attenuated recovery of heart rate turbulence early after myocardial infarction identifies patients at high risk for fatal or near-fatal arrhythmic events
2009
Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation
1996
Sentinel Symptoms in Patients with Unexplained Cardiac Arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)
2011
Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy
1991
Dissection of long-range heart rate variability
2004
Diagnostic criteria for vasovagal syncope based on a quantitative history
2005
Prognostic differences between atrial fibrillation and atrial flutter
2004
The North American vasovagal pacemaker study (VPS)
1999
Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
1986
Induction of heart rate and blood pressure turbulence in the electrophysiologic laboratory
2002
Identification of Patients Most Likely to Benefit From Implantable Cardioverter-Defibrillator Therapy
2000
The face of postural tachycardia syndrome – insights from a large cross‐sectional online community‐based survey
2019
Canadian Implantable Defibrillator Study (CIDS)
2000
Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences
1998
Origins of Heart Rate Variability
1999
A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels.
1987
Temporally localized contributions to measures of large-scale heart rate variability
1998
Tilt testing for syncope: a reappraisal.
2005
Canadian Implantable Defibrillator Study (CIDS): Study design and organization
1993
New-Onset Atrial Fibrillation
2001
Antiarrhythmic drugs and the cardiac sodium channel: current models.
1989
Developmental Changes in the Delayed Rectifier K+Channels in Mouse Heart
1996
Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
1993